Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects

Research Site, Kittanning

Research Site, Hockessin

Research Site, Woodbridge

Research Site, Alexandria

Research Site, Salem

Research Site, Raleigh

Research Site, Durham

Research Site, Charlotte

Research Site, Kinston

Research Site, Buford

Research Site, Athens

Research Site, Dalton

Research Site, Macon

Research Site, Jacksonville

Research Site#1, Coral Springs

Research Site#2, Coral Springs

Research Site, Coral Gables

Research Site, Bradenton

Research Site, Huntsville

Research Site, Knoxville

Research Site, Tupelo

Research Site, Brookhaven

Research Site, Columbus

Research Site, Columbus

Research Site, Saint Clair Shores

Research Site, Rochester Hills

Research Site, Kalamazoo

Research Site, North Platte

Research Site, Baton Rouge

Research Site, Shreveport

Research Site, Pine Bluff

Research Site, Dallas

Research Site, Dallas

Research Site, Arlington

Research Site, Mansfield

Research Site, Houston

Research Site, Houston

Research Site, San Antonio

Research Site, San Antonio

Research Site, Mission

Research Site, Austin

Research Site, Arvada

Research Site, Denver

Research Site, Nampa

Research Site, Phoenix

Research Site, Albuquerque

Research Site, Gallup

Research Site, Las Vegas

Research Site, Reno

Research Site, Granada Hills

Research Site, Escondido

Research Site, San Diego

Research Site, El Centro

Research Site, Porterville

Research Site, Fresno

Research Site, Plymouth

Research Site, Springfield

Research Site, Portsmouth